HIV-1 progression in hepatitis-C-infected drug users

Comment

J Macías et al. Lancet. 2001.

. 2001 Apr 28;357(9265):1362-3.

doi: 10.1016/S0140-6736(00)04483-4.

No abstract available

Comment on

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study.
Ledergerber B, Egger M, Opravil M, Telenti A, Hirschel B, Battegay M, Vernazza P, Sudre P, Flepp M, Furrer H, Francioli P, Weber R. Ledergerber B, et al. Lancet. 1999 Mar 13;353(9156):863-8. doi: 10.1016/s0140-6736(99)01122-8. Lancet. 1999. PMID: 10093977
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.
Greub G, Ledergerber B, Battegay M, Grob P, Perrin L, Furrer H, Burgisser P, Erb P, Boggian K, Piffaretti JC, Hirschel B, Janin P, Francioli P, Flepp M, Telenti A. Greub G, et al. Lancet. 2000 Nov 25;356(9244):1800-5. doi: 10.1016/s0140-6736(00)03232-3. Lancet. 2000. PMID: 11117912 Clinical Trial.